This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2023 Jul 31.

doi: 10.1001/jamainternmed.2023.3061. Online ahead of print.

Are New Alzheimer Drugs Better Than Older Drugs?

Susan Molchan¹, Adriane Fugh-Berman²

Affiliations

Affiliations

¹ Georgetown University Medical Center, Washington, DC.
² Department of Pharmacology and Physiology, Department of Family Medicine, Georgetown University Medical Center, Washington, DC.

PMID: 37523164
DOI: 10.1001/jamainternmed.2023.3061

Are New Alzheimer Drugs Better Than Older Drugs?

Susan Molchan et al. JAMA Intern Med. 2023.

. 2023 Jul 31.

doi: 10.1001/jamainternmed.2023.3061. Online ahead of print.

Authors

Susan Molchan¹, Adriane Fugh-Berman²

Affiliations

¹ Georgetown University Medical Center, Washington, DC.
² Department of Pharmacology and Physiology, Department of Family Medicine, Georgetown University Medical Center, Washington, DC.

PMID: 37523164
DOI: 10.1001/jamainternmed.2023.3061

No abstract available

Plain language summary

This Viewpoint explores whether there are benefits to drugs targeting β-amyloid protein in treating Alzheimer disease.

PubMed Disclaimer

Similar articles

Associations of Widowhood and β-Amyloid With Cognitive Decline in Cognitively Unimpaired Older Adults.
Biddle KD, Jacobs HIL, d'Oleire Uquillas F, Zide BS, Kirn DR, Properzi MR, Rentz DM, Johnson KA, Sperling RA, Donovan NJ. Biddle KD, et al. JAMA Netw Open. 2020 Feb 5;3(2):e200121. doi: 10.1001/jamanetworkopen.2020.0121. JAMA Netw Open. 2020. PMID: 32101313 Free PMC article.
Viewpoint: Amyloid-targeting New Therapies for Alzheimer's Disease: A Health Economics Perspective.
Jönsson L, Wimo A. Jönsson L, et al. J Prev Alzheimers Dis. 2023;10(2):349-352. doi: 10.14283/jpad.2023.76. J Prev Alzheimers Dis. 2023. PMID: 37357271 No abstract available.
Viewpoint: «Compounded Interest» in Alzheimer's Disease: Do New Amyloid-Targeting Treatments Justify Their Use.
Sampaio C. Sampaio C. J Prev Alzheimers Dis. 2023;10(3):333-335. doi: 10.14283/jpad.2023.70. J Prev Alzheimers Dis. 2023. PMID: 37357265 No abstract available.
Investigational medications for treatment of patients with Alzheimer disease.
Potter PE. Potter PE. J Am Osteopath Assoc. 2010 Sep;110(9 Suppl 8):S27-36. J Am Osteopath Assoc. 2010. PMID: 20926740 Review.
A step further towards multitarget drugs for Alzheimer and neuronal vascular diseases: targeting the cholinergic system, amyloid-β aggregation and Ca(2+) dyshomeostasis.
León R, Marco-Contelles J. León R, et al. Curr Med Chem. 2011;18(4):552-76. doi: 10.2174/092986711794480186. Curr Med Chem. 2011. PMID: 21143111 Review.

See all similar articles

Cited by

Investigating patient eligibility for anti-amyloid monoclonal antibody treatment of Alzheimer's disease: real-world data from an Austrian psychiatric memory clinic population.
Defrancesco M, Gizewski ER, Mangesius S, Galijasevic M, Virgolini I, Kroiss A, Marksteiner J, Jehle J, Doganyigit B, Hofer A. Defrancesco M, et al. BJPsych Open. 2024 Sep 23;10(5):e160. doi: 10.1192/bjo.2024.747. BJPsych Open. 2024. PMID: 39308280 Free PMC article.
Pharmacologic and Nutritional Interventions for Early Alzheimer's Disease: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
Zeng B, Tang C, Wang J, Yang Q, Ren Q, Liu X. Zeng B, et al. J Alzheimers Dis. 2024;99(4):1173-1186. doi: 10.3233/JAD-240161. J Alzheimers Dis. 2024. PMID: 38759015 Free PMC article.
Minimal clinically important difference in Alzheimer's disease: Rapid review.
Muir RT, Hill MD, Black SE, Smith EE. Muir RT, et al. Alzheimers Dement. 2024 May;20(5):3352-3363. doi: 10.1002/alz.13770. Epub 2024 Apr 1. Alzheimers Dement. 2024. PMID: 38561021 Free PMC article.
Diagnostic and progression biomarkers in cerebrospinal fluid of Alzheimer's disease patients.
Chatanaka MK, Prassas I, Diamandis EP. Chatanaka MK, et al. BMC Med. 2024 Feb 8;22(1):60. doi: 10.1186/s12916-024-03270-w. BMC Med. 2024. PMID: 38331825 Free PMC article.
New insights in animal models of neurotoxicity-induced neurodegeneration.
Sanfeliu C, Bartra C, Suñol C, Rodríguez-Farré E. Sanfeliu C, et al. Front Neurosci. 2024 Jan 8;17:1248727. doi: 10.3389/fnins.2023.1248727. eCollection 2023. Front Neurosci. 2024. PMID: 38260026 Free PMC article. Review.

See all "Cited by" articles

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems